News & Perspective

Feb 22, 2013

Feb 22, 2013

Flu activity continues its slow retreat

(CIDRAP News) – Some of the key markers that US officials use to track flu continued to tumble last week, though activity was still elevated in most parts of the country, according to the Centers for Disease Control and Prevention (CDC) today.

Nationally, the percentage of doctors visits for flulike illness fell from 3.2% to 2.8% last week, with all parts of the country still above regional baselines.

Feb 15, 2013

Feb 15, 2013

CDC: Flu activity continues to slow

(CIDRAP News) – The nation's flu markers show that the flu has probably peaked, though many states are still reporting plenty of infections and hospitalizations, the US Centers for Disease Control and Prevention (CDC) said today.

Though the percentage of doctors' visits for influenza-like illness (ILI) is still above baselines in all regions of the country, the overall national level fell from 3.6% to 3.2% last week, according to the CDC.

Feb 08, 2013

Feb 08, 2013

US flu ebbs but still causes considerable illness

(CIDRAP News) – US flu indicators continued their decline last week, though many states are still reporting brisk levels of flu activity, the Centers for Disease Control and Prevention (CDC) reported today.

Feb 07, 2013

Feb 07, 2013

Bacteria in meat show growing drug resistance, FDA says

(CIDRAP News) – An annual report released by the Food and Drug Administration (FDA) this week shows that antibiotic resistance in bacteria found in retail meat and poultry samples is continuing to increase, though not uniformly.

Feb 05, 2013

Feb 05, 2013

NIH launches trio of trials seeking better flu treatments

(CIDRAP News) – Three large, multi-center studies now in the enrollment stage will assess whether such approaches as a combination of antiviral drugs or the use of borrowed antibodies can improve on existing treatments for influenza, the National Institutes of Health (NIH) announced today.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»